BioCryst Pharmaceuticals Inc. (BCRX)
NASDAQ · Healthcare
BioCryst Pharmaceuticals Inc. Shareholder Equity 2009–2025
BioCryst Pharmaceuticals Inc. annual shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- BioCryst Pharmaceuticals Inc. shareholder equity as of December 31, 2025: -119.2M, a 74.96% decrease year-over-year.
- BioCryst Pharmaceuticals Inc. shareholder equity for 2025 were -119.2M, a 74.96% decrease from 2024.
- BioCryst Pharmaceuticals Inc. shareholder equity for 2024 were -475.9M, a 4.48% increase from 2023.
- BioCryst Pharmaceuticals Inc. shareholder equity for 2023 were -455.5M, a 54.63% increase from 2022.
- BioCryst Pharmaceuticals Inc. shareholder equity for 2022 were -294.6M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| BioCryst Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-119 |
| 2024 | $-476 |
| 2023 | $-456 |
| 2022 | $-295 |
| 2021 | $-107 |
| 2020 | $-19 |
| 2019 | $38 |
| 2018 | $49 |
| 2017 | $84 |
| 2016 | $2 |
| 2015 | $48 |
| 2014 | $76 |
| 2013 | $-1 |
| 2012 | $-0 |
| 2011 | $15 |
BioCryst Pharmaceuticals Inc. Shareholder Equity — FAQ
BioCryst Pharmaceuticals Inc. (BCRX) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BCRX's shareholder equity history?
The chart and table above show BioCryst Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.